How global drug manufacturers scale up production of COVID-19 vaccines

Posted by:

Proven technologies, such as InterTech Development Company’s mass flow leak test systems, enable medical technology innovators and pharmaceutical processors to immediately ramp up production of test systems and drugs to the warp speeds the pandemic requires.

Today however, the success of these superior InterTech test technologies is manifest in a wide range of applications—medical devices, high precision automotive components, and more.

InterTech’s microleak testing technology is used for both in-line testing and audit requirements for a wide range of life science products including:  wearables; combined products; and medical devices.

The most stringent leak test standards are readily achieved to typical limits of 8 microliters/minute (0.008 sccm)—or the equivalent hole size of 0.5 microns—with testing times of less than two seconds.

InterTech microleak testing solutions adhere to relevant ASTM standards, including ASTM F2338 and ASTM F3287.


Deterministic InterTech leak test technology

Posted by:

InterTech’s patented test technology eliminates the errors (both false positives and false negatives) inherent in previously used pressure testing methods.

A leading manufacturer of COVID-19 rapid testing systems has been able to triple production to help meet the demands of this global emergency—and do so with a savings of more than US$1 million.

Time-to-market for high throughput manufacture of fast clinical testing instruments was reduced by 50%.

Product quality traceability is assured by deterministic InterTech leak test technology that eliminates potential for lapses in human operator judgements over entire product lifecycle.